Eric Jia-Sobota, Founder, Author at EverGlade Consulting - Page 2 of 6

Eric Jia-Sobota, Founder

Eric Jia-Sobota is the National Leader of EverGlade’s Consulting Practice and the Founder of the Company. Eric’s consulting experience spans almost two decades across a breadth of industries, including, Federal Contracting, Life Sciences, Nonprofit, Technology, Construction, Healthcare, and others. View Eric's resume at https://ericjia-sobota.com/

Eric Jia-Sobota
Wearable medical device

ARPA-H Solicits Proposals For REACT Program

Advanced Research Projects Agency (ARPA-H) Solicits Proposals for Resilient Extended Automatic Cell Therapies (REACT) Program The Advanced Research Projects Agency for Health (ARPA-H) is actively seeking innovative proposals through the Resilient Extended Automatic Cell Therapies (REACT) program, employing a Master Announcement Instruction (MAI) strategy for proposal submissions. This strategy enables proposers to tailor their submissions […]

ARPA-H Solicits Proposals For REACT Program Read More »

BARDA Post-Award represented with a digital drawing of virus and microscope

Effective Post-Award Management of a BARDA Contract

The Biomedical Advanced Research and Development Authority (BARDA) plays a pivotal role in the United States’ preparedness for public health emergencies. BARDA contracts support the development, procurement, and deployment of medical countermeasures critical for safeguarding public health during crises. Once awarded a BARDA contract, effective post-award management becomes paramount to ensure the successful execution of

Effective Post-Award Management of a BARDA Contract Read More »

medical countermeasures development

Guide to BARDA Funding Broad Agency Announcement Update

The Biomedical Advanced Research and Development Authority (BARDA), a USG agency that operates within the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), has recently released a new, modernized Broad Agency Announcement (BAA) with the goal of enhancing efficiency, improving responsiveness, and reducing

Guide to BARDA Funding Broad Agency Announcement Update Read More »

Female scientist in a hazmat suit researching WMD-related security challenges

DTRA BAA Weapons of Mass Destruction Amendment

DTRA BAA Outlines New Opportunity to Identify and Counter Weapons of Mass Destruction (WMD) through the Strategic Trends Research Initiative The Defense Threat Reduction Agency (DTRA) has amended its Broad Agency Announcement (BAA) to offer new funding opportunities through the Strategic Trends Research Initiative (STRI) for identifying and countering Weapons of Mass Destruction (WMD), defined

DTRA BAA Weapons of Mass Destruction Amendment Read More »

CHIPS Act Funding Alert

CHIPS Act Pre-Funding Alert

CHIPS Act Program Begins Accepting Pre-Applications for Large Supply Chain Projects In a move to secure America’s leadership in the semiconductor sector, the U.S. Department of Commerce (DoC) announced on Friday, the start of its rolling pre-application process for large-scale supply chain projects and wafer manufacturing facilities. The projects that qualify must have capital investments

CHIPS Act Pre-Funding Alert Read More »

JPEO Funding - military man with gas mask and rifle

A Guide to JPEO Funding

A Guide to JPEO Funding: Application Process, Financial and Technical Requirements In the complex ecosystem of defense and homeland security, the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) holds a distinct role. This specialized office under the Department of Defense (DoD) focuses on safeguarding the United States military and its

A Guide to JPEO Funding Read More »

Iron and Steel for the ROSIE project

The ROSIE Project – New ARPA-E FOA

In the quest to combat climate change, industries worldwide are seeking innovative solutions to reduce their carbon footprint. One such initiative is the Revolutionizing Ore to Steel to Impact Emissions (ROSIE) Project, spearheaded by the Advanced Research Projects Agency-Energy (ARPA-E). This initiative aims to revolutionize the iron and steel industry by introducing groundbreaking technologies that

The ROSIE Project – New ARPA-E FOA Read More »

Scientist with test tubes for NIAID Funding Guide

A Guide to NIAID Funding

A Guide to NIAID Funding: Application Process, Financial and Technical Requirements The National Institute of Allergy and Infectious Diseases (NIAID) is a part of the U.S. National Institutes of Health (NIH), focusing on research related to infectious, immunologic, and allergic diseases. Securing NIAID funding can be a significant milestone for researchers and organizations in these

A Guide to NIAID Funding Read More »

Female scientist genomic sequencing

New JPEO RFI for Advanced Genomic Sequencing and In-field Sample Preparation

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) has recently issued a Request for Information (RFI) aimed at market research and planning. The primary objective of this RFI is to identify potential vendors capable of providing advanced genomic sequencing and/or associated sample preparation capabilities. The JPEO-CBRND is particularly interested in

New JPEO RFI for Advanced Genomic Sequencing and In-field Sample Preparation Read More »

Female scientist with vile and PPE for DTRA Funding Guide

A Guide to DTRA Funding

A Guide to DTRA Funding: Application Process, Financial and Technical Requirements The Defense Threat Reduction Agency (DTRA) is a U.S. Department of Defense (DoD) agency that focuses on countering weapons of mass destruction. DTRA offers numerous funding opportunities for research and development projects, but navigating the technical and financial requirements can be challenging. This guide

A Guide to DTRA Funding Read More »

Scroll to Top
A yellow lab flask with Donald Trump hair and a red tie.

Webinar: R&D Funding in Life Sciences: What's Ahead in Trump 2.0?

Join us on Jan 15, 2025, at 12:00pm ET for a deep dive into the future of R&D Funding in Life Sciences.